VBI Vaccines Raises $71.9 Million in Public Offering

VBI Vaccines, a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, announced the closing of its public offering which raised approximately US$71.9 Million.

Read the full press release here: https://www.vbivaccines.com/wire/oct-2017-offering-closing/